skip to main content

Lowenstein Sandler LLP | The contents of this website contain attorney advertising. | Results may vary depending on your particular facts and legal circumstances.

Search
Smart Search Icon
Header Search

Recent Searches

Clear all Searches

Relevant Insights

Featured Content

view all search results
Search Close
Hamburger
profile Icon for Mobile

Daniel L. Forman

Partner

New York
T: +1 212.419.5904 F: +1 212.262.7402 dforman@lowenstein.com
  • BIO
  • EXPERIENCE
  • NEWS & INSIGHTS

See more section

Daniel L. Forman represents public and private companies, investment banks, private equity sponsors, and venture funds in a wide range of capital markets transactions, including IPOs, secondary equity offerings, convertible debt offerings, debt offerings, tender offers, debt restructurings, and private placements, as well as related corporate and securities matters.

Daniel has deep knowledge of and experience with sophisticated financing transactions, including equity-linked offerings, PIPEs, confidentially marketed offerings, registered direct offerings, reverse mergers and SPACS.

Daniel also has significant experience advising public companies both large and small on their SEC reporting obligations and corporate governance matters.

He works with clients across numerous industries, including life sciences, technology, retail and consumer brands, industrials and financial institutions, among others.

Daniel maintains an active pro bono practice, including work for the International Refugee Assistance Project, Legal Services NYC, New York Legal Assistance Group, and the Billion Oyster Project. He also serves on the Advisory Board of Legal Outreach, an organization that prepares urban youth from underserved communities in New York City to achieve academic excellence.

  • The underwriters in $2.7 billion and $1.8 billion secondary equity offerings of Nasdaq, Inc. by selling stockholders
  • Sarepta Therapeutics and Transmedics Group Inc. in various convertible senior notes offerings and exchanges
  • The placement agent in a $600 million convertible senior notes transaction for Repligen Corporation
  • Aurora Acquisition Corp. in its de-SPAC transaction with Better Home & Finance Company
  • Church & Dwight Co., Inc. in its $400 million registered notes offering and Suburban Propane Partners, L.P. in its $650 million high-yield notes offering
  • L Catterton in connection with a private placement of $150 million in aggregate principal amount of non-convertible preferred stock plus warrants to purchase ordinary shares in Despegar.com
  • Solid Biosciences Inc. in its initial public offering and Eloxx Pharmaceuticals, Inc. in a follow-on offering
  • The underwriters in equity offerings for Biohaven Ltd., Intra-Cellular Therapies, Inc., Novavax, Inc. and Vanda Pharmaceuticals

*The above transactions were completed prior to joining Lowenstein Sandler.

Education

  • Benjamin N. Cardozo School of Law (J.D. 2008)

    The George Washington University (B.A. 2002)

Admissions

  • New York